- 1. *Threshold Mass Concentration
- (UMLS (HL7) C1264644) =Quantitative Concept =Kind of quantity;
| - 29. Thrombin NIH; soybean trypsin inhibitor
- [Thrombin plus soybean trypsin inhibitor. For use in identifying fibrn degredation products. ( HL7V3.0 )] (UMLS (HL7) C1553432) =Intellectual Product =MaterialEntityAdditive;
|
- 2. *Threshold Substance Concentration
- (UMLS (HL7) C1264646) =Quantitative Concept =Kind of quantity;
| - 30. Thrombin NIH; soybean trypsin inhibitor (Fibrin Degradation Products)
- (UMLS (HL7) C1550068) =Biomedical or Dental Material; ;
=Additive/Preservative; |
- 3. THR Gene
- [Thyroid Hormone Receptor Genes (Nuclear Receptor Family), c-erbA alpha and c-erbA beta, encode two isoforms each of c-erbA proteins (Thyroid Hormone Receptor) that specifically bind thyroid hormones and, thereby activated, regulate target gene transcription. (NCI) ( NCI )] (UMLS (NCI) C0919499) Thyroid Hormone Receptor Gene =Gene or Genome ;
| - 31. thrombin receptor
- [cell surface proteins that specifically bind thrombin and trigger changes in the behavior of blood cells. ( CSP )] (UMLS (CSP) C0076552) =Amino Acid, Peptide, or Protein; Receptor ;
=membrane protein; Cell Surface Receptor |
- 4. THRA
- [This gene plays a role in receptor signaling and regulation of transcription. It is involved in thyroid hormone binding. ( NCI )] (UMLS (NCI) C0242987) =Gene or Genome ;
| - 32. Thrombin-Antithrombin Complex
- [A protease involved in clotting ( NCI )] (UMLS (NCI) C0052128) =Amino Acid, Peptide, or Protein; Enzyme ;
|
- 5. THRB
- [This gene plays a role in receptor signaling and regulation of transcription. It is involved in inner ear development and color vision. ( NCI )] (UMLS (NCI) C0242988) =Gene or Genome ;
| - 33. Thrombocidin 1
- (UMLS (NCI) C1455542) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
|
- 6. THREAT PREM LABOR-UNSPEC
- [ ] (UMLS (ICD9CM) C0156713) =Disease or Syndrome
| - 34. Thrombocidin 2
- (UMLS (NCI) C1455541) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
|
- 7. THREATEN ABORT-ANTEPART
- [ ] (UMLS (ICD9CM) C1812628) Threatened abortion, antepartum =Disease or Syndrome ;
| - 35. Thrombocyte (platelet)
- (UMLS (HL7) C1547925) =Intellectual Product =Specimen Source Codes;
|
- 8. THREATENED ABORT-DELIVER
- [ ] (UMLS (ICD9CM) C0156606) =Disease or Syndrome
| - 36. Thrombocyte (platelet)
- (UMLS (HL7) C1550664) =Body Substance =SpecimenEntityType;
|
- 9. Threatened abortion, unspecified as to episode of care
- [ ] (UMLS (ICD9CM) C0156605) =Disease or Syndrome
| - 37. thrombocytopenia
- [decrease in the number of blood platelets. ( CSP )] (UMLS (NCI) C0040034) =Disease or Syndrome =Blood Platelet Disorders;
=Aldrich syndrome; Purpura, Thrombocytopenic; HEMOLYTIC UREMIC SYND; Purpura, Thrombocytopenic |
- 10. Threatened premature labor
- [ ] (UMLS (ICD9CM) C0473390) =Pathologic Function
| - 38. Thrombocytopenia Due to Immune Destruction
- (UMLS (NCI) C0272286) =Disease or Syndrome
|
- 11. Threatened premature labor, antepartum
- [ ] (UMLS (ICD9CM) C0156714) =Disease or Syndrome
| - 39. Thrombocytopoiesis
- [formation of blood platelets. ( CSP )] (UMLS (NCI) C0221145) =Organ or Tissue Function ;
=hematopoiesis; |
- 12. Three Affiliated Tribes of the Fort Berthold Reser
- (UMLS (HL7) C1554519) =Population Group =NativeEntityContiguous;
| - 40. Thrombocytosis
- [increased number of platelets in the peripheral blood. ( CSP )] (UMLS (NCI) C0836924) =Disease or Syndrome =Blood Platelet Disorders;
MPD =Essential Thrombocytemia |
- 13. three dimensional imaging/topography
- [images which show length, width and depth of the object; can be generated or simulated by assembling multiple tomographic images with the aid of a computer; topography is the physical or natural features of an object or entity and their structural relationships; for photographic 3-D images see HOLOGRAPHY. ( CSP )] (UMLS (CSP) C1171319) =Diagnostic Procedure =imaging/visualization/scanning;
| - 41. thrombohemorrhagic event
- [A process that involves either a blood clot or bleeding, such as a heart attack or stroke. ( NCI )] (UMLS (NCI) C1336741) =Disease or Syndrome ;
|
- 14. three dimensional treatment planning
- [ ] (UMLS (CSP) C0598931) =Health Care Activity ;
| - 42. thrombolysis
- [The process of breaking up and dissolving blood clots. ( NCI )] (UMLS (CSP) C0520997) =Clinical Attribute
|
- 15. Three micron Giemsa stain
- [Stain, Three micron Giemsa ( HL7V3.0 )] (UMLS (HL7) C1293975) =Laboratory Procedure =ObservationMethod;
| - 43. thrombomodulin
- [vascular endothelium surface glycoprotein which binds thrombin and accelerates its activation of protein C, thus exerting an anticoagulant and antiinflammatory effect. ( CSP )] (UMLS (CSP) C0145779) =Amino Acid, Peptide, or Protein; Receptor ;
=Blood Coagulation Factor; |
- 16. Three Prime Repair Exonuclease 1 Gene
- [This gene plays a role in cellular DNA damage checkpoints. ( NCI )] (UMLS (NCI) C1336670) TREX1;
TREX1 Gene =Gene or Genome ; | - 44. thrombophlebitis
- [(throm-bo-fleh-BY-tis) Inflammation of a vein that occurs when a blood clot forms. ( NCI )] (UMLS (NCI) C0040046) =Disease or Syndrome =phlebitis;
venous thrombosis |
- 17. Three Prime Repair Exonuclease 2 Gene
- [This gene is involved in DNA repair and in the maintenance of DNA integrity. ( NCI )] (UMLS (NCI) C1336671) TREX2;
TREX2 Gene =Gene or Genome ; | - 45. THROMBOPHLEBITIS MIGRANS
- (UMLS (ICD9CM) C0152250) =Disease or Syndrome ;
|
- 18. three times a day at institution-specified times
- [Three times a day at institution specified time ( HL7V3.0 )] (UMLS (HL7) C1610169) TID =Temporal Concept ;
=Repeat; GTSAbbreviation | - 46. thrombopoietic factor
- [humoral regulator of production of blood platelets. ( CSP )] (UMLS (CSP) C0597581) =Organic Chemical; Biologically Active Substance =hematopoietic growth factor;
|
- 19. Three times a week
- [Three times per week. ( NCI )] (UMLS (NCI) C0556987) =Temporal Concept
| - 47. THROMBOS HEMORRHOIDS NOS
- [ ] (UMLS (ICD9CM) C0235326) =Disease or Syndrome
|
- 20. THREONINE
- [alpha-amino beta-hydroxy butyric acid, a natural amino acid essential for optimal growth in infants and for nitrogen equilibrium in adults. ( CSP )] (UMLS (NCI) C0040005) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Biologically Active Substance =Amino Acids, Essential;
Amino Acids, Neutral; hydroxyaminoacid; primary aminoacid | - 48. thrombosis
- [formation, development, or presence of a thrombus. ( CSP )] (UMLS (NCI) C0040053) =Pathologic Function =Embolism and Thrombosis;
blood vessel occlusion =venous thrombosis; coronary occlusion/thrombosis; coronary thrombosis; Purpura, Thrombotic Thrombocytopenic; Embolism and thrombosis of unspecified site; venous thrombosis |
- 21. threonine deaminase
- [A pyridoxal-phosphate protein that catalyzes the deamination of THREONINE to 2-ketobutyrate and AMMONIA. The role of this enzyme can be biosynthetic or biodegradative. In the former role it supplies 2-ketobutyrate required for ISOLEUCINE biosynthesis, while in the latter it is only involved in the breakdown of threonine to supply energy. This enzyme was formerly listed as EC 4.2.1.16. ( MSH )] (UMLS (CSP) C0040008) =Amino Acid, Peptide, or Protein; Enzyme ;
| - 49. Thrombospondin
- [multifunctional glycoprotein secreted by endothelial cells and by alpha granules of platelets following activation by thrombin; interacts with a wide variety of molecules to play a role in platelet aggregation, tumor metastasis, vascular smooth muscle growth, and microorganism adhesion. ( CSP )] (UMLS (NCI) C0076560) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
=Adhesion Molecule; Extracellular Matrix Protein |
- 22. Threshold
- [The lowest limit at which something becomes detectable or relevant. ( NCI )] (UMLS (NCI) C0449864) =Functional Concept ;
| - 50. Thrombospondin Type I Domain 2 Protein
- [Encoded by human THSD2 Gene, Thrombospondin Type I Domain 2 Protein contains a furin-like cysteine-rich region and is similar to thrombospondin type 1 domain-containing proteins. Furin-like domains have been found in proteins involved in signal transduction by receptor tyrosine kinases. The function of this protein has not been determined. (NCI) ( NCI )] (UMLS (NCI) C1259459) THSD2 =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
|
- 23. Throat
- (UMLS (HL7) C1547926) =Intellectual Product =Specimen Source Codes;
| - 51. thrombosthenin
- [ ] (UMLS (CSP) C0076562) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
|
- 24. Throat
- (UMLS (HL7) C1550663) =Body Substance =SpecimenEntityType;
| - 52. Thromboxane
- [physiologically active compounds found in many organs of the body, formed in vivo from the prostaglandin endoperoxides and causing platelet aggregation, contraction of arteries, and other biological effects; important mediators of the actions of polyunsaturated fatty acids transformed by cyclooxygenase. ( CSP )] (UMLS (NCI) C0040061) =Eicosanoid; Biologically Active Substance ;
=eicosanoid; |
- 25. Throat
- (UMLS (NCI) C0230069) =Body Location or Region
| - 53. thromboxane receptor
- [Cell surface proteins that bind THROMBOXANES with high affinity and trigger intracellular changes influencing the behavior of cells. Some thromboxane receptors act via the inositol phosphate and diacylglycerol second messenger systems. ( MSH )] (UMLS (CSP) C0076566) =Amino Acid, Peptide, or Protein; Receptor ;
|
- 26. Throat Cancer
- [Carcinoma, predominantly squamous cell, arising from epithelial cells of the larynx or pharynx. — 2004 ( NCI )] (UMLS (NCI) C0740339) Throat Carcinoma =Neoplastic Process ;
| - 54. through
- [Condition must be true throughout the execution and the service is interrupted (asynchronously) as soon as the condition turns false (asynchronous WHILE loop). The service must be interruptible. ( HL7V3.0 )] (UMLS (HL7) C1550549) =Temporal Concept =ActRelationshipCheckpoint;
|
- 27. Thrombectomy
- [Surgery performed with the purpose of removing a thrombus. ( NCI )] (UMLS (NCI) C0162578) =Therapeutic or Preventive Procedure ;
| - 55. thrush
- [ ] (UMLS (CSP) C0326586) =Bird
|
- 28. Thrombin
- [Thrombin. Accelerates clotting. ( HL7V3.0 )] (UMLS (HL7) C1550090) =Intellectual Product ;
=MaterialEntityAdditive; | |